|
ITSN1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.69064762189919E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.58190135937753E-11 |
| Normal-vs-Stage2 |
7.77879982649665E-10 |
| Normal-vs-Stage3 |
1.98640004445139E-09 |
| Normal-vs-Stage4 |
2.33929997595084E-09 |
| Stage1-vs-Stage2 |
9.652400E-02 |
| Stage1-vs-Stage3 |
7.532400E-01 |
| Stage1-vs-Stage4 |
3.198400E-01 |
| Stage2-vs-Stage3 |
1.922650E-01 |
| Stage2-vs-Stage4 |
4.350800E-01 |
| Stage3-vs-Stage4 |
5.454000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.03614944086439E-12 |
| Normal-vs-AfricanAmerican |
4.183600E-04 |
| Normal-vs-Asian |
1.69073999999325E-05 |
| Caucasian-vs-AfricanAmerican |
5.988600E-01 |
| Caucasian-vs-Asian |
5.363800E-01 |
| AfricanAmerican-vs-Asian |
9.593800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.36720034871996E-10 |
| Normal-vs-Female |
1.74027459109993E-12 |
| Male-vs-Female |
7.972200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.69370004080116E-09 |
| Normal-vs-Age(41-60Yrs) |
4.01512156855688E-12 |
| Normal-vs-Age(61-80Yrs) |
8.38910052536335E-11 |
| Normal-vs-Age(81-100Yrs) |
1.476490E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.806200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.407200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.894000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.767000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.073000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.814400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.211000E-01 |
| Classical-VS-Follicular |
5.57100000020405E-07 |
| Classical-VS-Other |
7.769200E-01 |
| Classical-VS-Normal |
5.76589997969279E-10 |
| Tall-VS-Follicular |
7.082400E-03 |
| Tall-VS-Other |
9.169600E-01 |
| Tall-VS-Normal |
3.16749999995647E-06 |
| Follicular-VS-Other |
1.896820E-01 |
| Follicular-VS-Normal |
1.63036251166204E-12 |
| Other-VS-Normal |
2.063900E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.93098878501041E-14 |
| Normal-vs-N1 |
1.31580002449283E-09 |
| N0-vs-N1 |
8.528600E-01 |
|
|
